RecallDepth
Class III Terminated

Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg), packaged in cartons containing 3 wallets of 28 Tablets each, Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United Stated, Manufactured by: Lupin Limited, Pithampur, (M.P.) - 454775, India, 244896, The individual wallet NDC 68180-904-11 and the carton NDC 68180-904-13.

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
November 19, 2021
Posted
December 8, 2021
Recall Number
D-0264-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4113 cartons
Firm Location
Baltimore, MD, United States

Reason for Recall

Subpotent Drug

Distribution

nationwide within the United States

Lot / Code Info

Lot #: L000784 and L000785, Exp. Date May 2022

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class III Drug recalls